Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Questcorp Mining Engages Marketing Consulting Firm Spark Newswire July 2, 2025 Lithium Universe LtdPV SOLAR CELL Recycling Acquisition Legal Due Diligence Complete July 2, 2025 Acquisition Legal DD Complete July 2, 2025